Privi Speciality Chemicals Ltd
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]
- Market Cap ₹ 8,965 Cr.
- Current Price ₹ 2,292
- High / Low ₹ 2,394 / 1,031
- Stock P/E 47.4
- Book Value ₹ 282
- Dividend Yield 0.09 %
- ROCE 17.9 %
- ROE 18.7 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 8.10 times its book value
- The company has delivered a poor sales growth of 9.50% over past five years.
- Company has a low return on equity of 11.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
152 | 151 | 152 | 185 | 236 | 250 | 1,295 | 1,255 | 1,391 | 1,578 | 1,712 | 2,038 | |
119 | 126 | 128 | 162 | 202 | 213 | 1,080 | 1,048 | 1,195 | 1,394 | 1,383 | 1,592 | |
Operating Profit | 33 | 25 | 23 | 24 | 34 | 36 | 215 | 207 | 197 | 184 | 329 | 446 |
OPM % | 22% | 17% | 15% | 13% | 14% | 15% | 17% | 16% | 14% | 12% | 19% | 22% |
1 | 1 | 0 | 0 | 3 | 4 | 66 | 43 | 38 | 21 | 21 | 18 | |
Interest | 3 | 3 | 4 | 5 | 6 | 6 | 36 | 23 | 25 | 68 | 97 | 84 |
Depreciation | 3 | 2 | 3 | 4 | 5 | 5 | 55 | 69 | 73 | 105 | 122 | 127 |
Profit before tax | 28 | 21 | 17 | 15 | 26 | 29 | 189 | 158 | 137 | 31 | 132 | 254 |
Tax % | 34% | 33% | 36% | 39% | 25% | 26% | 24% | 26% | 26% | 28% | 26% | 25% |
19 | 14 | 11 | 9 | 19 | 22 | 144 | 117 | 102 | 22 | 98 | 189 | |
EPS in Rs | 13.54 | 9.92 | 7.68 | 2.41 | 5.16 | 5.50 | 36.83 | 29.93 | 26.00 | 5.75 | 25.03 | 48.41 |
Dividend Payout % | 10% | 25% | 33% | 42% | 29% | 45% | 4% | 7% | 8% | 0% | 8% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | 30% |
5 Years: | 10% |
3 Years: | 14% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | 30% |
5 Years: | 11% |
3 Years: | 25% |
TTM: | 93% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 46% |
3 Years: | 23% |
1 Year: | 102% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 12% |
3 Years: | 12% |
Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 13 | 14 | 14 | 38 | 38 | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
Reserves | 35 | 43 | 49 | 33 | 48 | 64 | 564 | 675 | 768 | 783 | 881 | 1,062 |
29 | 29 | 34 | 60 | 67 | 57 | 493 | 517 | 897 | 1,043 | 900 | 856 | |
11 | 20 | 18 | 23 | 24 | 28 | 269 | 291 | 424 | 478 | 368 | 516 | |
Total Liabilities | 88 | 105 | 114 | 154 | 176 | 188 | 1,364 | 1,522 | 2,128 | 2,343 | 2,189 | 2,473 |
33 | 62 | 73 | 94 | 102 | 115 | 564 | 565 | 666 | 982 | 999 | 993 | |
CWIP | 12 | 8 | 5 | 3 | 3 | 1 | 30 | 174 | 370 | 93 | 27 | 56 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 43 | 43 | 51 | 51 | 62 | 62 |
43 | 36 | 36 | 57 | 72 | 72 | 727 | 740 | 1,042 | 1,217 | 1,101 | 1,363 | |
Total Assets | 88 | 105 | 114 | 154 | 176 | 188 | 1,364 | 1,522 | 2,128 | 2,343 | 2,189 | 2,473 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
12 | 32 | 16 | 4 | 15 | 34 | 216 | 152 | 15 | 55 | 362 | 304 | |
-19 | -25 | -13 | -20 | -13 | -14 | -174 | -242 | -324 | -141 | -118 | -144 | |
7 | -7 | -3 | 17 | -3 | -21 | 29 | 19 | 324 | 70 | -239 | -135 | |
Net Cash Flow | 0 | 0 | -0 | 0 | -0 | 0 | 72 | -71 | 15 | -16 | 6 | 25 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51 | 42 | 41 | 50 | 49 | 47 | 61 | 69 | 75 | 73 | 77 | 72 |
Inventory Days | 61 | 50 | 49 | 69 | 71 | 76 | 145 | 158 | 254 | 293 | 229 | 239 |
Days Payable | 12 | 28 | 10 | 18 | 17 | 22 | 74 | 91 | 140 | 117 | 108 | 134 |
Cash Conversion Cycle | 100 | 65 | 80 | 101 | 103 | 101 | 132 | 136 | 189 | 249 | 198 | 177 |
Working Capital Days | 82 | 48 | 47 | 65 | 69 | 67 | 99 | 115 | 151 | 160 | 149 | 140 |
ROCE % | 50% | 29% | 23% | 17% | 22% | 23% | 30% | 14% | 11% | 6% | 12% | 18% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
2d - Annual Secretarial Compliance Report for FY ended March 31, 2025 submitted, confirming regulatory adherence.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 May - Scheduled analyst meeting on May 21, 2025; no unpublished info to be discussed.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12 May - Transcript of Analyst/Investors Meet held on Tuesday, May 06,2025
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
6 May - Audio recording of Q4 and FY25 financial results analyst call released.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
5 May - Investor presentation - Financial & Operation Review for quarter and year ended March 31,2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Oct 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024TranscriptPPTREC
-
Nov 2023TranscriptPPTREC
-
Aug 2023TranscriptNotesPPTREC
-
Aug 2023TranscriptNotesPPTREC
-
Jun 2023TranscriptNotesPPTREC
-
Feb 2023TranscriptNotesPPT
-
May 2022TranscriptPPT
-
Jan 2022Transcript PPT
-
Jul 2017TranscriptNotesPPT
-
Jul 2016TranscriptNotesPPT
-
Nov 2011TranscriptPPT
Business Profile[1]
Privi Speciality Chemicals Limited, formerly Fairchem Speciality Limited, is India’s largest manufacturer and exporter of aroma chemicals, holding a >20% global market share in ten products. The company specializes in manufacturing, supplying, and exporting bulk aroma and fragrance chemicals.[2]